Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 31Peripheral Blood Stem Cell Transplantation 26Cyclophosphamide 24Busulfan 21Cyclosporine 20Mycophenolic Acid 19Cytarabine 16Antilymphocyte Serum 15Whole-Body Irradiation 14Tacrolimus 14Radiotherapy 13Filgrastim 13Methotrexate 11Melphalan 10Etoposide 10Cord Blood Stem Cell Transplantation 9Methylprednisolone 8sargramostim 6Transplantation 5Idarubicin 5Thiotepa 4Flow Cytometry 4Daunorubicin 4Cytogenetic Analysis 4Immunologic Techniques 3Granulocyte Colony-Stimulating Factor 3Gemtuzumab 3tipifarnib 2merphos 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × Staining and Labeling × Classical hematology × Clear all
NCT00052520 2017-03-29

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Fred Hutchinson Cancer Center

Phase 1/2 Completed
37 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡